Compounds > 5-bromo-4-chloro-3-indolyl beta-galactoside
Page last updated: 2024-08-24

5-bromo-4-chloro-3-indolyl beta-galactoside and diazeniumdiolate

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with diazeniumdiolate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Gu, L; Li, S; Qi, Q; Shi, Y; Song, J; Wang, PG1

Other Studies

1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and diazeniumdiolate

ArticleYear
A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
    Archiv der Pharmazie, 2006, Volume: 339, Issue:7

    Topics: Animals; Antineoplastic Agents; Azo Compounds; beta-Galactosidase; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Galactose; Galactosides; Glycosylation; Indoles; Nitric Oxide; Nitric Oxide Donors; Staining and Labeling

2006